Pediatric COVID-19 Vaccines: What Parents, Practitioners, and Policy Makers Need to Know

Pediatric COVID-19 Vaccines: What Parents, Practitioners, and Policy Makers Need to Know

This Viewpoint discusses the Food and Drug Administration granting Emergency Use Authorization of the mRNA COVID-19 vaccine BNT162b2 for children aged 5 to 11 years and the role that will play in keeping children, schools, and communities safe.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA : the journal of the American Medical Association 2021-12, Vol.326 (22), p.2257-2258
Hauptverfasser: Moss, William J, Gostin, Lawrence O, Nuzzo, Jennifer B
Format: Artikel
Sprache:eng
Schlagworte:
Administrative Personnel
Adolescent
Child
Child, Preschool
Children
Coronaviruses
COVID-19
COVID-19 vaccines
COVID-19 Vaccines - adverse effects
General & Internal Medicine
Health Policy
Humans
Life Sciences & Biomedicine
Medicine, General & Internal
mRNA
Parents
Pediatrics
Schools
Science & Technology
United States
Vaccine Efficacy
Vaccines
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This Viewpoint discusses the Food and Drug Administration granting Emergency Use Authorization of the mRNA COVID-19 vaccine BNT162b2 for children aged 5 to 11 years and the role that will play in keeping children, schools, and communities safe.
ISSN:0098-7484
1538-3598
DOI:10.1001/jama.2021.20734